Afssaps wants further measures to cut French benzodiazepine use
This article was originally published in Scrip
The French medicines agency Afssaps has outlined further measures to reduce the use of benzodiazepines in the country. The measures are detailed in a report on the consumption of the product class, which includes anti-anxiety medicines and sleeping pills.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.